Antonello Quadri

Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

Mario Scartozzi, Italo Bearzi, Chiara Pierantoni et al. · Journal of Clinical Oncology · 2007 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

Mario Scartozzi, Italo Bearzi, Alessandra Mandolesi et al. · BMC Cancer · 2009 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer

Giordano Beretta, G. Michetti, M. Ori Belometti et al. · British Journal of Cancer · 2000 · 50 citations · Full text

Medicine, Oncology, Pharmacology +15

A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy

George Dranitsaris, Pauline Leung, R. Ciotti et al. · PharmacoEconomics · 2001 · 18 citations

Medicine, Oncology, Pharmacology +7